- Home
- CHMI vs TLSA Comparison
CHMI vs TLSA Comparison
Compare CHMI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHMI | TLSA |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 182.7M |
| IPO Year | 2013 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CHMI | TLSA |
|---|---|---|
| Price | $2.52 | $1.50 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | 221.8K | ★ 372.2K |
| Earning Date | 11-06-2025 | 05-06-2025 |
| Dividend Yield | ★ 15.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $40,202,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $31.73 | N/A |
| P/E Ratio | $137.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.17 | $0.63 |
| 52 Week High | $3.68 | $2.60 |
Technical Indicators
Market Signals| Indicator | CHMI | TLSA |
|---|---|---|
| Relative Strength Index (RSI) | 46.73 | 44.96 |
| Support Level | $2.47 | $1.44 |
| Resistance Level | $2.78 | $1.61 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 17.74 | 61.89 |
Price Performance
Historical ComparisonAbout CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.